Clinical Trials
16 trialsNCT04038255 2025-09-09
Mindfulness Based Smoking Cessation Among Cancer Survivors
University of Miami
Phase 4 Terminated
NCT05075538 2024-01-17
I-SPARC
Jules Bordet Institute
Phase 4 Terminated
NCT00819832 2023-03-24
Anderson Circulating Tumor Cell Burden (CTCB) Study
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT00381095 2021-01-20
COPE
Pfizer
Phase 4 Terminated
NCT00588835 2020-11-30
ACE
Radboud University Medical Center
Phase 4 Terminated
NCT01189409 2019-08-28
Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
British Columbia Cancer Agency
Phase 4 Terminated
NCT02839889 2019-03-05
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Hospice of Henderson County, Inc.
Phase 4 Terminated
NCT01817699 2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4 Terminated
NCT00075179 2018-11-07
Natrecor in Pulmonary Hypertension
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT00495378 2016-12-20
RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia
Ortho Biotech Products, L.P.
Phase 4 Terminated
NCT00944372 2016-09-09
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
Mallinckrodt
Phase 4 Terminated
NCT02749825 2016-04-25
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Pharmatech
Phase 4 Terminated
NCT00747916 2015-07-16
Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")
CSA Medical, Inc.
Phase 4 Terminated
NCT00352859 2014-12-30
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Bayer
Phase 4 Terminated
NCT00358111 2014-05-13
Study of LUMA Cervical Imaging System as Adjunct to Colposcopy
SpectraScience
Phase 4 Terminated
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated